Adherence and Substance Use

  • A. Meade EgglestonEmail author
  • Jennifer L. Strauss
  • Vito S. Guerra
  • Patrick S. Calhoun


As reported in other chapters of this volume, the misuse of alcohol and other substances can contribute to treatment non-adherence across a range of medical and mental health service settings. In this chapter, our focus is specific to non-adherence in the context of treatment programs that directly target substance misuse and substance use disorders. In such treatment settings, problems with adherence are prevalent and, as elaborated below, significantly impact treatment outcomes.


Nicotine Dependence Motivational Interview Substance Abuse Treatment Methadone Maintenance Treatment Illicit Substance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Battjes RJ. Smoking as an issue in alcohol and drug abuse treatment. Addict Behav. 1988;13(3):225–230.PubMedCrossRefGoogle Scholar
  2. 2.
    Stark MJ. Dropping out of substance-abuse treatment – a clinically oriented review. Clin Psychol Rev. 1992;12(1):93–116.CrossRefGoogle Scholar
  3. 3.
    National Institute on Drug Abuse. Main findings for drug abuse treatment units: September 1982. Data from the National Drug and Alcoholism Treatment Utilization Survey (NDATUS). Washington, DC: Govt Printing Office; 1983. Series F, No. 10, DHHS Publication No. ADM 83–1284.Google Scholar
  4. 4.
    Bastian LA, Molner SL, Fish LL, McBride CM. Smoking cessation and adherence. In: Bosworth HB, Oddone EZ, Weinberger M, eds. Patient treatment adherence concepts, interventions and measurement. Mahwah, NJ: Lawrence Erlbaum Associates; 2006:125–146.Google Scholar
  5. 5.
    Grant BF. Alcohol consumption, alcohol abuse and alcohol dependence. The United States as an example. Addiction. 1994;89:1357–1365.PubMedCrossRefGoogle Scholar
  6. 6.
    Willenbring M. Alcoholism isn’t what it used to be: new research on the nature and diagnosis of alcohol use disorders. NIAAA Videoconference Series http:// Accessed May 7, 2009.
  7. 7.
    Room R, Babor T, Rehm J. Alcohol and public health. Lancet. 2005;365(9458):519–530.PubMedGoogle Scholar
  8. 8.
    National Institute on Drug Abuse. 2008 NIDA InfoFacts: Nationwide trends. Accessed May 7, 2009.
  9. 9.
    Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol consumption on diabetes mellitus. Ann Intern Med. 2004;140(3):211–219.PubMedGoogle Scholar
  10. 10.
    McFadden CB, Brensinger CM, Berlin JA, Townshend RR. Systematic review of the effect of daily alcohol intake on blood pressure. Am J Hypertens. 2005;18:276–286.PubMedCrossRefGoogle Scholar
  11. 11.
    Martell BA, O’Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146(2):116–127.PubMedGoogle Scholar
  12. 12.
    Terry MB, Zhang FF, Kabat G, et al. Lifetime alcohol intake and breast cancer risk. Ann Epidemiol. 2006;16(3):230–240.Google Scholar
  13. 13.
    Grant BF, Dawson DA, Stinson FS, Chou SP, Dufour MC, Pickering RP. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991–1992 and 2001–2002. Drug Alcohol Depend. 2004;74(3):223–234.PubMedCrossRefGoogle Scholar
  14. 14.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th Ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
  15. 15.
    Compton WM, Thomas Y, Stinson F, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64(5):566–576.PubMedCrossRefGoogle Scholar
  16. 16.
    Hasin D, Stinson F, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64(7):830–842.PubMedCrossRefGoogle Scholar
  17. 17.
    Hughes AL. The prevalence of illicit drug use in six metropolitan areas in the United States: results from the 1991 National Household Survey on Drug Abuse. Br J Addict. 1992;87(10):1481–1485.PubMedCrossRefGoogle Scholar
  18. 18.
    National Institute on Drug Abuse. National household survey on drug abuse: main findings 1985. U.S. Department of health and human services PHS, alcohol, drug abuse, and mental health administration. Rockville, MD: Department of Health and Human Services; 1990.Google Scholar
  19. 19.
    Substance Abuse and Mental Health Services Administration. Summary of findings from the 2000 national household survey on drug abuse. Rockville, MD: Department of Health and Human Services, Office of Applied Studies; 2001. DHHS Publication No. SMA 01–3549.Google Scholar
  20. 20.
    Carroll K, ed. Improving compliance with alcoholism. Rockville, MD: NIAAA; 1977. Project MATCH Monograph Series; No. 6, DHHS Publication No. 97–4143.Google Scholar
  21. 21.
    Haynes RB. Strategies to improve compliance with referrals, appointments, and prescribed medical regimens. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in health care. Baltimore, MD: Johns Hopkins University Press; 1979:2–3.Google Scholar
  22. 22.
    Bosworth HB. Medical treatment adherence in patient treatment adherence: Concepts, interventions and measurements. Mahwah, NJ: Lawrence Erlbaum Associates; 2006.Google Scholar
  23. 23.
    Baekeland F, Lundwall L. Dropping out of treatment: a critical review. Psychol Bull. 1975;82(5):738–783.PubMedCrossRefGoogle Scholar
  24. 24.
    Wickizer T, Maynard C, Atherly A, Frederick M. Completion rates of clients discharged from drug and alcohol treatment programs in Washington State. Am J Public Health. 1994;84(2):215–221.PubMedCrossRefGoogle Scholar
  25. 25.
    Substance Abuse and Mental Health Services Administration. National survey of substance abuse treatment (NSSAT): Data for 2000 and 2001. Washington, DC: Department of Health and Human Services; 2002. DHHS Publication No. SMA 98–3176.Google Scholar
  26. 26.
    Hubbard RL, Arsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg H. Drug abuse treatment: A national study of effectiveness. Chapel Hill, NC: University of North Carolina Press; 1989.Google Scholar
  27. 27.
    McKay JR, McLellan AT, Alterman AI, Cacciola JS, Rutherford MJ, O’Brien CP. Predictors of participation in aftercare sessions and self-help groups following completion of intensive outpatient treatment for substance abuse. J Stud Alcohol. 1998;59(2):152–162.PubMedGoogle Scholar
  28. 28.
    Hoffman JA, Caudill BD, Koman JJ, Luckey JW. Psychosocial treatments for cocaine abuse: 12-month treatment outcomes. J Subst Abuse Treat. 1996;13(1):3–11.PubMedCrossRefGoogle Scholar
  29. 29.
    Zhang Z, Friedmann PD, Gerstein DR. Does retention matter? Treatment duration and improvement in drug use. Addiction. 2003;98(5):673–684.PubMedCrossRefGoogle Scholar
  30. 30.
    McCaul ME, Svikis DS, Moore RD. Predictors of outpatient treatment retention: patient versus substance use characteristics. Drug Alcohol Depend. 2001;62(1):9–17.PubMedCrossRefGoogle Scholar
  31. 31.
    Kleinman P, Kang S, Lipton D, Woody GE, Kemp J, Millman RB. Retention of cocaine abusers in outpatient psychotherapy. Am J Drug Alcohol Abus. 1992;18:29–43.CrossRefGoogle Scholar
  32. 32.
    Agosti V, Nunes E, Ocepeck-Welikson K. Patient factors related to early attrition from an outpatient cocaine research clinic. Am J Drug Alcohol Abus. 1996;22:29–39.CrossRefGoogle Scholar
  33. 33.
    Saxon JJ, Wells EA, Fleming C, Jackson TR, Calsyn DA. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction. 1996;91:1197–1209.PubMedCrossRefGoogle Scholar
  34. 34.
    Himmelstein DU, Woodhandler S. Care denied: U.S. residents who are unable to obtain needed medical services. Am J Public Health. 1995;85:341–344.PubMedCrossRefGoogle Scholar
  35. 35.
    Sterling RC, Gottheil E, Weinstein SP, Serota R. The effect of therapist/patient race-and-sex matching in individual treatment. Addiction. 2001;96:1015–1022.PubMedCrossRefGoogle Scholar
  36. 36.
    Project Match Research Group. Matching alcoholism treatments to client heterogeneity: project MATCH posttreatment drinking outcomes. J Stud Alcohol. 1997;58(1):7–29.Google Scholar
  37. 37.
    Higgins ST, Alessi SM, Dantona RL. Voucher-based incentives: a substance abuse treatment innovation. Addict Behav. 2002;27:887–910.PubMedCrossRefGoogle Scholar
  38. 38.
    U.S. Preventive Services Task Force. Screening for illicit drug use: U.S. preventive services task force recommendation statement. Rockville, MD: Agency for Healthcare Research and Quality; 2008. AHRQ Publication No. 08-05108-EF-3.Google Scholar
  39. 39.
    U.S. Preventive Services Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse. Rockville, MD: Agency for Healthcare Research and Quality; 2004. AHRQ Publication No. 04-0533A.Google Scholar
  40. 40.
    Cleary P, Miller M, Bush BT, Warburg MM, Delbanco TL, Aronson MD. Prevalence and recognition of alcohol abuse in a primary care population. Am J Med. 1988;85:466–471.PubMedCrossRefGoogle Scholar
  41. 41.
    Buchsbaum D, Buchanan R, Poses RM, Schnoll SH, Lawton MJ. Physician detection of drinking problems in patients attending a general medicine practice. J Gen Intern Med. 1992;7:517–521.PubMedCrossRefGoogle Scholar
  42. 42.
    Friedmann PD, McCullough D, Saitz R. Screening and intervention for illicit drug abuse: a national survey of primary care physicians and psychiatrists. J Gen Intern Med. 2001;161:248–251.Google Scholar
  43. 43.
    Edlund MJ, Unützer J, Wells KB. Clinician screening and treatment of alcohol, drug, and mental problems in primary care: results from healthcare for communities. Med Care. 2004;42(12):1158–1166.PubMedCrossRefGoogle Scholar
  44. 44.
    Yarnall KSH, Pollak KI, Østbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93(4):635–641.Google Scholar
  45. 45.
    Spandorfer JM, Israel Y, Turner BJ. Primary care physicians’ views on screening and management of alcohol abuse: inconsistencies with national guidelines. J Fam Pract. 1999;48(11):899–902.PubMedGoogle Scholar
  46. 46.
    U.S. Preventive Services Task Force. Counseling to prevent tobacco use and tobacco-caused disease. Rockville, MD: Agency for Healthcare Research and Quality; 2003. AHRQ Publication No. 04-0526.Google Scholar
  47. 47.
    Barbor TF, Higgins-Biddle JC, Saunders JB, Monteiro M. AUDIT: The alcohol use disorders identification test: Guidelines for use in primary health care. Geneva: World Health Organization; 2001.Google Scholar
  48. 48.
    Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med. 1998;158(16):1789–1795.PubMedCrossRefGoogle Scholar
  49. 49.
    Reinert DF, Allen JP. The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research. Alcohol Clin Exp Res. 2002;26(2):272–279.PubMedCrossRefGoogle Scholar
  50. 50.
    Reinert DF, Allen JP. The alcohol use disorders identification test: an update of research findings. Alcohol Clin Exp Res. 2007;31(2):185–199.PubMedCrossRefGoogle Scholar
  51. 51.
    Bradley KA, Bush KR, Epler AJ, et al. Two brief alcohol-screening tests from the Alcohol Use Disorders Identification Test (AUDIT): validation in a female Veterans Affairs patient population. Arch Intern Med. 2003;163(7):821–829.PubMedCrossRefGoogle Scholar
  52. 52.
    Bradley KA, Williams EC, Achtmeyer CE, Volpp B, Collins BJ, Kivlahan DR. Implementation of evidence-based alcohol screening in the Veterans Health Administration. Am J Manag Care. 2006;12(10):597–606.PubMedGoogle Scholar
  53. 53.
    Dawson DA, Grant BF, Stinson FS. The AUDIT-C: screening for alcohol use disorders and risk drinking in the presence of other psychiatric disorders. Compr Psychiatry. 2005;46(6):405–416.PubMedCrossRefGoogle Scholar
  54. 54.
    Lefforge NL, Donohue B, Strada MJ. Improving session attendance in mental health and substance abuse settings: a review of controlled studies. Behav Therap. 2007;38(1):1–22.CrossRefGoogle Scholar
  55. 55.
    Festinger DS, Lamb RJ, Kirby KC, Marlowe DB. The accelerated intake: a method for increasing initial attendance to outpatient cocaine treatment. J Appl Behav Analy. 1996;29:387–389.CrossRefGoogle Scholar
  56. 56.
    Stasiewicz PR, Stalker R. A comparison of three "interventions" on pretreatment dropout rates in an outpatient substance abuse clinic. Addict Behav. 1999;24:579–582.PubMedCrossRefGoogle Scholar
  57. 57.
    Gariti P, Alterman AI, Holub-Beyer E, Volpicelli JR, Prentice N, O’Brien CP. Effects of an appointment reminder call on patient show rates. J Substan Abuse Treat. 1995;12:207–212.CrossRefGoogle Scholar
  58. 58.
    Zweben A, Bonner M, Chaim G, Stanton P. Facilitative strategies for retaining the alcohol-dependent client in outpatient treatment. Alcohol Treat Q. 1988;5:3–23.CrossRefGoogle Scholar
  59. 59.
    Zweben A, Li S. The efficacy of role induction in preventing early dropout from outpatient treatment of drug dependency. Am J Drug Alcohol Abuse. 1981;8:171–183.PubMedCrossRefGoogle Scholar
  60. 60.
    Miller D. Addictions and trauma recovery: an integrated approach. Psychiatric Quarter. 2002;73(2):157–170.CrossRefGoogle Scholar
  61. 61.
    Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003;71(5):843–861.PubMedCrossRefGoogle Scholar
  62. 62.
    Miller WR, Rollnick S. Motivational interviewing: Preparing people to change addictive behavior. New York, NY: The Guilford Press; 1991.Google Scholar
  63. 63.
    Kabela E, Kadden RM. Practical strategies for improving client compliance with treatment. In: Carroll KM, ed. Improving compliance with alcoholism treatment. Vol NIH publication No. 97-4143. Bethesda, MD: National Institute of Health, National Institute of Alcohol Abuse and Alcoholism (NIAAA); 1997:15–50.Google Scholar
  64. 64.
    Comfort M, Loverro J, Kaltenback K. A search for strategies to engage women in substance abuse treatment. Soc Work in Health Care. 2000;31:59–70.CrossRefGoogle Scholar
  65. 65.
    Holder HD. Cost benefits of substance abuse treatment: an overview of results from alcohol and drug abuse. J Ment Health Policy Econ. 1998;1(1):23–29.PubMedCrossRefGoogle Scholar
  66. 66.
    French MT. Economic evaluation of drug abuse treatment programs: methodology and findings. Am J Drug Alcohol Abuse. 1995;21(1):111–1135.PubMedCrossRefGoogle Scholar
  67. 67.
    Substance Abuse and Mental Health Services Administration. Results from the 2004 National Survey of Drug Use and Health: National findings. Rockville, MD: Office of Applied Studies; 2005. DHHS Publication No. SMA 05-4062.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • A. Meade Eggleston
    • 1
    Email author
  • Jennifer L. Strauss
    • 2
  • Vito S. Guerra
    • 3
  • Patrick S. Calhoun
    • 2
  1. 1.Veterans Affairs Mid-Atlantic Mental Illness, Research, and Clinical CenterDurham Veterans Affairs Medical CenterDurhamUSA
  2. 2.Medical PsychologyDuke University Medical CenterDurhamUSA
  3. 3.PsychologyDurham Veterans Affairs Medical CenterDurhamUSA

Personalised recommendations